Antigone Kotsaki
Athens, ESYE31, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Precision Immunotherapy to Improve Sepsis Outcomes: The ImmunoSep Randomized Clinical Trial.
Journal: JAMA
Published: December 08, 2025
Author Correction: A consensus immune dysregulation framework for sepsis and critical illnesses.
Journal: Nature medicine
Published: October 28, 2025
Blood Biomarker and Raman Analysis of Leukocytes in the Multicenter Intelligence Trials: At the Intensive Care Unit (Intelligence-1) and the Emergency Department (Intelligence-2).
Journal: Shock (Augusta, Ga.)
Published: September 25, 2025
29-mRNA host response signatures for classification of bacterial infection, viral infection and disease progression in COVID-19 pneumonia: a post hoc analysis of the SAVE-MORE randomized clinical trial.
Journal: Intensive care medicine experimental
Published: January 12, 2025
International multi-cohort analysis identifies novel framework for quantifying immune dysregulation in critical illness: results of the SUBSPACE consortium.
Journal: bioRxiv : the preprint server for biology
Published: November 28, 2024
A consensus immune dysregulation framework for sepsis and critical illnesses.
Journal: Nature medicine
Published: November 20, 2024
Modulation of Metabolomic Profile in Sepsis According to the State of Immune Activation.
Journal: Critical care medicine
Published: October 17, 2024
Population pharmacokinetics/pharmacodynamics of minocycline plus rifampicin in patients with complicated skin and skin structure infections caused by MRSA.
Journal: The Journal of antimicrobial chemotherapy
Published: February 23, 2024
qSOFA combined with suPAR for early risk detection and guidance of antibiotic treatment in the emergency department: a randomized controlled trial.
Journal: Critical care (London, England)
Published: December 16, 2023
Evaluation of the Novel Sepsis Biomarker Host-Derived Delta-like Canonical Notch Ligand 1-A Secondary Analysis of 405 Patients Suffering from Inflammatory or Infectious Diseases.
Journal: International journal of molecular sciences
Published: April 04, 2023
ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol.
Journal: BMJ open
Published: January 05, 2023
Last Updated: 09/26/2026